Orexo
Orexo AB, a leading pharmaceutical company headquartered in Sweden, focuses on developing innovative treatments for addiction and pain management. Founded in 1995, Orexo has established a strong presence in Europe and North America, with a commitment to addressing unmet medical needs through advanced drug delivery technologies. The company’s core products, including Zubsolv, a sublingual film for opioid dependence, exemplify its unique approach to patient care. Orexo's dedication to research and development has positioned it as a key player in the pharmaceutical industry, with notable achievements in improving treatment outcomes for patients struggling with addiction. With a robust pipeline and a focus on sustainable growth, Orexo continues to make significant strides in enhancing the quality of life for individuals facing complex health challenges.
DitchCarbon Score
How does Orexo's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Orexo's score of 49 is higher than 82% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Orexo's reported carbon emissions
In 2023, Orexo reported total carbon emissions of approximately 1,660,000 kg CO2e. This figure includes Scope 1 emissions of about 273,000 kg CO2e, primarily from mobile combustion, and Scope 2 emissions of approximately 73,000 kg CO2e. The majority of their emissions, around 1,314,000 kg CO2e, fall under Scope 3, which encompasses various categories such as capital goods, business travel, and employee commuting. Comparatively, in 2022, Orexo's total emissions were about 1,845,000 kg CO2e, indicating a reduction of approximately 185,000 kg CO2e year-on-year. This reduction reflects their ongoing commitment to improving sustainability practices, although specific reduction targets or initiatives have not been disclosed. Orexo's headquarters is located in Sweden (SE), and while they have not set formal reduction targets through initiatives like the Science Based Targets initiative (SBTi), their emissions data demonstrates a proactive approach to managing their carbon footprint. The company continues to monitor and report on its emissions across all relevant scopes, contributing to broader industry efforts in climate responsibility.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 284,000 | 000,000 |
| Scope 2 | 73,000 | 00,000 |
| Scope 3 | 1,488,000 | 0,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Orexo is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
